Patents by Inventor Sophie Glatt

Sophie Glatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treatment Using Anti-IL-17A/F Antibodies
    Publication number: 20230287100
    Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
    Type: Application
    Filed: October 11, 2022
    Publication date: September 14, 2023
    Inventors: Sophie Glatt, Lucian Ionescu, Margaret Jones, Ruth Oliver, Stevan Graham Shaw, Foteini Strimenopoulou, Venkata Pavan Kumar Vajjah
  • Methods of Treatment Using Anti-IL-17A/F Antibodies
    Publication number: 20230279093
    Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
    Type: Application
    Filed: October 11, 2022
    Publication date: September 7, 2023
    Inventors: Sophie Glatt, Lucian Ionescu, Margaret Jones, Ruth Oliver, Stevan Graham Shaw, Foteini Strimenopoulou, Venkata Pavan Kumar Vajjah
  • Methods of treatment using anti-IL-17A/F antibodies
    Patent number: 11492396
    Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: November 8, 2022
    Assignee: UCB BIOPHARMA SRL
    Inventors: Sophie Glatt, Lucian Ionescu, Margaret Jones, Ruth Oliver, Stevan Graham Shaw, Foteini Strimenopoulou, Venkata Pavan Kumar Vajjah
  • Methods of Treatment Using Anti-IL-17A/F Antibodies
    Publication number: 20190292255
    Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
    Type: Application
    Filed: October 26, 2016
    Publication date: September 26, 2019
    Inventors: Sophie Glatt, Lucian Ionescu, Margaret Jones, Ruth Oliver, Stevan Graham Shaw, Foteini Strimenopoulou, Venkata Pavan Kumar Vajjah
  • New Salt And Medical Use
    Publication number: 20140248252
    Abstract: The present invention is directed to 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt thereof for the treatment of a disease associated with elevated blood uric acid levels, such as hyperuricemia or gout. The invention is also directed to the tosylate salt of 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 4, 2014
    Applicant: PFIZER LIMITED
    Inventors: Zahid Ali, Kenneth John Butcher, Richard Philip Butt, Stephen John Felstead, Sophie Glatt, Ruth Mitchell McKernan, Maninder Panesar